Pillstats
Capsule, Gelatin Coated

Hydrochlorothiazide

Hydrochlorothiazide

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US1 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCC03AA03
RxCUI (US)5487
US makers1 labelers
Packages4
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.009$0.018$0.026$0.035Dec 2025Apr 2026Jul 2026
$0.028
Latest avg · Jul 22, 2026
-7%
Since Dec 17, 2025
1
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

8371.7K2.5K3.3K2025 Q12025 Q22025 Q32025 Q42026 Q1
1.4K
Rx · 2026 Q1
58K
Units dispensed
-52%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Actavis Pharma, Inc.unknown4SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Nov 19, 2025
    RESOLVEDShortage resolved: Hydrochlorothiazide Capsule (Teva Pharmaceuticals USA, Inc.)

    Hydrochlorothiazide Capsule — reported in shortage by Teva Pharmaceuticals USA, Inc.. Therapeutic category: Cardiovascular.

  • Nov 19, 2025
    SHORTAGEDrug shortage: Hydrochlorothiazide Capsule (Teva Pharmaceuticals USA, Inc.)

    Hydrochlorothiazide Capsule — reported in shortage by Teva Pharmaceuticals USA, Inc.. Therapeutic category: Cardiovascular.